Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Obstetrics/Gynecology

RSS  

Articles

  • Progestin eyed for use in contraceptive gel

    Your next patient is a 17-year-old female who is seeking contraception for pregnancy prevention. She is not sure if she wants to take the Pill, and says she's leery of wearing a contraceptive patch. What options can you offer her?
  • Finally! Emergency contraception given approval by FDA for nonprescription sale

    One of the final barriers to availability of emergency contraception (EC) has been toppled with the Food and Drug Administration (FDA) approval of nonprescription sales of the EC drug, Plan B. The drug is manufactured by Barr Pharmaceuticals of Pomona, NY, and marketed by its Duramed subsidiary.
  • STD Quarterly: Repeat chlamydia infection: Improve partner notification and treatment

    The next patient in your exam room is a 25-year-old single woman who has come in for her quarterly contraceptive injection. At her last visit, she tested positive for chlamydia. She was given a prescription to treat the infection and counseled to have her partner come in for treatment as well. When her lab results are returned prior to your present exam, results are positive for chlamydia.
  • The Pill & bone health: New study eyes impact

    Revamp your oral contraceptive (OC) counseling: Results of a new study indicate that Pill use is not associated with an increase or a decrease in fracture risk.
  • Talk with teens about sex: Unwanted sex common?

    In taking a sexual history from your next patient, a 15-year-old female tells you she is in a monogamous relationship with her boyfriend. She discloses that he often uses marijuana, and sometimes they have sex without a condom. When you ask further about the relationship, she tells you that sometimes she has unwanted sex with the boyfriend rather than risk an argument.
  • Full October 2006 Issue in PDF

  • STD Quarterly: Stay vigilant in stemming gonorrhea

    While strides have been made in stemming gonorrhea, clinicians are advised to keep the sexually transmitted disease (STD) on the radar screen. Preliminary new data from the Centers for Disease Control and Prevention (CDC) show sharp increases in reported gonorrhea cases since 2000 in seven states: Alaska, California, Hawaii, Nevada, Oregon, Utah, and Washington.
  • Banish the myths about fertility, contraception

    Review the following scenario: a patient has used oral contraceptives for 15 years, starting her first pill pack at age 28. Now at age 43, she tells you, "I had three children by 28 when I started using the Pill. I got divorced three years ago, and now I'm remarried. Why can't I get pregnant? It must be the Pill." What is your counseling strategy?
  • The Peritoneum — To Close or Not to Close During a Cesarean Section?

    There continues to be controversy regarding the merits and risks of one- or two-layer closure of the uterus during cesarean section. Also, although opinions abound concerning whether or not to close the peritoneum during a cesarean section, until now there has been sparse evidence in the literature to back either side.
  • Managing Poor Response to Hormone Therapy

    Hormone therapy is highly effective for relieving symptoms associated with menopause and for preventing postmenopausal osteoporosis. Some women, however, respond unsatisfactorily to standard doses of hormone therapy.